Mreininger (Talk | contribs) |
Mreininger (Talk | contribs) |
||
Line 329: | Line 329: | ||
Each PCR was loaded on a preparative gel and cut out before undergoing PCR-purification. | Each PCR was loaded on a preparative gel and cut out before undergoing PCR-purification. | ||
<br><br>• Golden Gate Assembly of <a href="#BB1_14" class="bgscroll"> BB1_14</a>, <a href="#BB1_15" class="bgscroll"> BB1_15</a>, BB2_01 (unsuccessful, even with new BBa_23101 promoter), BB2_05 (unsuccessful), <a href="#BB2_06" class="bgscroll"> BB2_06</a>, <a href="#BB2_07" class="bgscroll"> BB2_07</a>, <a href="#BB2_08" class="bgscroll"> BB2_08</a>, <a href="#BB2_09" class="bgscroll"> BB2_09</a>, <a href="#BB2_10" class="bgscroll"> BB2_10</a>, <a href="#BB2_12" class="bgscroll"> BB2_12</a>, <a href="#BB2_14" class="bgscroll"> BB2_14</a>, <a href="#BB2_15" class="bgscroll"> BB2_15</a>, <a href="#BB2_16" class="bgscroll"> BB2_16</a>, C-PPP_01 (unsuccessful)</br> | <br><br>• Golden Gate Assembly of <a href="#BB1_14" class="bgscroll"> BB1_14</a>, <a href="#BB1_15" class="bgscroll"> BB1_15</a>, BB2_01 (unsuccessful, even with new BBa_23101 promoter), BB2_05 (unsuccessful), <a href="#BB2_06" class="bgscroll"> BB2_06</a>, <a href="#BB2_07" class="bgscroll"> BB2_07</a>, <a href="#BB2_08" class="bgscroll"> BB2_08</a>, <a href="#BB2_09" class="bgscroll"> BB2_09</a>, <a href="#BB2_10" class="bgscroll"> BB2_10</a>, <a href="#BB2_12" class="bgscroll"> BB2_12</a>, <a href="#BB2_14" class="bgscroll"> BB2_14</a>, <a href="#BB2_15" class="bgscroll"> BB2_15</a>, <a href="#BB2_16" class="bgscroll"> BB2_16</a>, C-PPP_01 (unsuccessful)</br> | ||
− | GG-products are then transformed into competent cells. Colonies with specific antibiotic resistances were selected | + | GG-products are then transformed into competent cells. Colonies with specific antibiotic resistances were selected by using antibiotic-containing media. The next day, positives clones were confirmed via an OneTaq colony PCR and a gel electrophoresis before a Miniprep was made.</br> |
<br>• Sent for Sequencing: <a href="#BB1_14" class="bgscroll"> BB1_14</a>, <a href="#BB1_15" class="bgscroll"> BB1_15</a>, <a href="#BB2_01" class="bgscroll"> BB2_01</a>, <a href="#BB2_05" class="bgscroll"> BB2_05</a>, <a href="#BB2_06" class="bgscroll"> BB2_06</a>, <a href="#BB2_07" class="bgscroll"> BB2_07</a>, <a href="#BB2_08" class="bgscroll"> BB2_08</a>, <a href="#BB2_09" class="bgscroll"> BB2_09</a>, <a href="#BB2_10" class="bgscroll"> BB2_10</a>, <a href="#BB2_12" class="bgscroll"> BB2_12</a></br> | <br>• Sent for Sequencing: <a href="#BB1_14" class="bgscroll"> BB1_14</a>, <a href="#BB1_15" class="bgscroll"> BB1_15</a>, <a href="#BB2_01" class="bgscroll"> BB2_01</a>, <a href="#BB2_05" class="bgscroll"> BB2_05</a>, <a href="#BB2_06" class="bgscroll"> BB2_06</a>, <a href="#BB2_07" class="bgscroll"> BB2_07</a>, <a href="#BB2_08" class="bgscroll"> BB2_08</a>, <a href="#BB2_09" class="bgscroll"> BB2_09</a>, <a href="#BB2_10" class="bgscroll"> BB2_10</a>, <a href="#BB2_12" class="bgscroll"> BB2_12</a></br> | ||
<br>• Interlab Challenge 2017: Performance of the measurements. For more information, please visit our <a href="https://2017.igem.org/Team:BOKU-Vienna/InterLab" target="_blank">Interlab</a> site.</br> | <br>• Interlab Challenge 2017: Performance of the measurements. For more information, please visit our <a href="https://2017.igem.org/Team:BOKU-Vienna/InterLab" target="_blank">Interlab</a> site.</br> | ||
Line 395: | Line 395: | ||
− | GG-products are then transformed into competent cells. Colonies with specific antibiotic resistances were selected | + | GG-products are then transformed into competent cells. Colonies with specific antibiotic resistances were selected by using antibiotic-containing media. The next day, positives clones were confirmed via an OneTaq colony PCR and a gel electrophoresis before a Miniprep was made.</br> |
<br>• Yeast S266C made electro-competent</br> | <br>• Yeast S266C made electro-competent</br> | ||
<br>• Sent for Sequencing: <a href="#BB1_16" class="bgscroll"> BB1_16</a>, <a href="#BB1_17" class="bgscroll"> BB1_17</a>, <a href="#BB1_18" class="bgscroll"> BB1_18</a>, <a href="#BB3_02" class="bgscroll"> BB3_02</a>, <a href="#BB3_05" class="bgscroll"> BB3_05</a>, <a href="#C-PPP_01" class="bgscroll"> C-PPP_01</a></br> | <br>• Sent for Sequencing: <a href="#BB1_16" class="bgscroll"> BB1_16</a>, <a href="#BB1_17" class="bgscroll"> BB1_17</a>, <a href="#BB1_18" class="bgscroll"> BB1_18</a>, <a href="#BB3_02" class="bgscroll"> BB3_02</a>, <a href="#BB3_05" class="bgscroll"> BB3_05</a>, <a href="#C-PPP_01" class="bgscroll"> C-PPP_01</a></br> | ||
Line 480: | Line 480: | ||
Each PCR was loaded on a preparative gel and cut out before undergoing PCR-purification. | Each PCR was loaded on a preparative gel and cut out before undergoing PCR-purification. | ||
<br><br>• Golden Gate Assembly of <a href="#BB1_19" class="bgscroll"> BB1_19</a>, <a href="#BB2_19" class="bgscroll"> BB2_19</a>, <a href="#BB2_25" class="bgscroll"> BB2_25</a>, <a href="#BB2_26" class="bgscroll"> BB2_26</a>, <a href="#BB2_27" class="bgscroll"> BB2_27</a>, <a href="#BB2_28" class="bgscroll"> BB2_28</a>, <a href="#BB2_29" class="bgscroll"> BB2_29</a>, <a href="#BB2_30" class="bgscroll"> BB2_30</a>, <a href="#BB2_31" class="bgscroll"> BB2_31</a>, <a href="#BB2_32" class="bgscroll"> BB2_32</a>, <a href="#BB2_33" class="bgscroll"> BB2_33</a>, <a href="#BB2_34" class="bgscroll"> BB2_34</a>, BB3_01 (unsuccessful), <a href="#BB3_02" class="bgscroll"> BB3_02</a>, BB3_03 (unsuccessful), <a href="#BB3_06" class="bgscroll"> BB3_06</a>, <a href="#BB3_10" class="bgscroll"> BB3_10</a>, <a href="#BB3_13" class="bgscroll"> BB3_13</a>, <a href="#BB3_14" class="bgscroll"> BB3_14</a>, <a href="#BB3_15" class="bgscroll"> BB3_15</a>, <a href="#BB3_24" class="bgscroll"> BB3_24</a></br> | <br><br>• Golden Gate Assembly of <a href="#BB1_19" class="bgscroll"> BB1_19</a>, <a href="#BB2_19" class="bgscroll"> BB2_19</a>, <a href="#BB2_25" class="bgscroll"> BB2_25</a>, <a href="#BB2_26" class="bgscroll"> BB2_26</a>, <a href="#BB2_27" class="bgscroll"> BB2_27</a>, <a href="#BB2_28" class="bgscroll"> BB2_28</a>, <a href="#BB2_29" class="bgscroll"> BB2_29</a>, <a href="#BB2_30" class="bgscroll"> BB2_30</a>, <a href="#BB2_31" class="bgscroll"> BB2_31</a>, <a href="#BB2_32" class="bgscroll"> BB2_32</a>, <a href="#BB2_33" class="bgscroll"> BB2_33</a>, <a href="#BB2_34" class="bgscroll"> BB2_34</a>, BB3_01 (unsuccessful), <a href="#BB3_02" class="bgscroll"> BB3_02</a>, BB3_03 (unsuccessful), <a href="#BB3_06" class="bgscroll"> BB3_06</a>, <a href="#BB3_10" class="bgscroll"> BB3_10</a>, <a href="#BB3_13" class="bgscroll"> BB3_13</a>, <a href="#BB3_14" class="bgscroll"> BB3_14</a>, <a href="#BB3_15" class="bgscroll"> BB3_15</a>, <a href="#BB3_24" class="bgscroll"> BB3_24</a></br> | ||
− | GG-products are then transformed into competent cells. Colonies with specific antibiotic resistances were selected | + | GG-products are then transformed into competent cells. Colonies with specific antibiotic resistances were selected by using antibiotic-containing media. The next day, positives clones were confirmed via an OneTaq colony PCR and a gel electrophoresis before a Miniprep was made.</br> |
<br>• Preculture of DH10B <i>E. coli</i> strain made chemically competent</br> | <br>• Preculture of DH10B <i>E. coli</i> strain made chemically competent</br> | ||
<br>• Yeast cells transformed with the Cas9 plasmid</br> | <br>• Yeast cells transformed with the Cas9 plasmid</br> | ||
Line 575: | Line 575: | ||
<p> | <p> | ||
<br>• Golden Gate Assembly of <a href="#BB2_36" class="bgscroll"> BB2_36</a>, <a href="#BB3_07" class="bgscroll"> BB3_07</a>, <a href="#BB3_10" class="bgscroll"> BB3_10</a>, <a href="#BB3_11" class="bgscroll"> BB3_11</a>, <a href="#BB3_13" class="bgscroll"> BB3_13</a>, <a href="#BB3_14" class="bgscroll"> BB3_14</a>, <a href="#BB3_17" class="bgscroll"> BB3_17</a>, <a href="#BB3_18" class="bgscroll"> BB3_18</a>, <a href="#BB3_19" class="bgscroll"> BB3_19</a>, <a href="#BB3_20" class="bgscroll"> BB3_20</a>, <a href="#BB3_21" class="bgscroll"> BB3_21</a>, <a href="#BB3_22" class="bgscroll"> BB3_22</a>, <a href="#BB3_23" class="bgscroll"> BB3_23</a>, <a href="#BB3_24" class="bgscroll"> BB3_24</a>, <a href="#C-PPP_01" class="bgscroll"> C-PPP_03</a>, <a href="#C-PPP_04" class="bgscroll"> C-PPP_04</a></br> | <br>• Golden Gate Assembly of <a href="#BB2_36" class="bgscroll"> BB2_36</a>, <a href="#BB3_07" class="bgscroll"> BB3_07</a>, <a href="#BB3_10" class="bgscroll"> BB3_10</a>, <a href="#BB3_11" class="bgscroll"> BB3_11</a>, <a href="#BB3_13" class="bgscroll"> BB3_13</a>, <a href="#BB3_14" class="bgscroll"> BB3_14</a>, <a href="#BB3_17" class="bgscroll"> BB3_17</a>, <a href="#BB3_18" class="bgscroll"> BB3_18</a>, <a href="#BB3_19" class="bgscroll"> BB3_19</a>, <a href="#BB3_20" class="bgscroll"> BB3_20</a>, <a href="#BB3_21" class="bgscroll"> BB3_21</a>, <a href="#BB3_22" class="bgscroll"> BB3_22</a>, <a href="#BB3_23" class="bgscroll"> BB3_23</a>, <a href="#BB3_24" class="bgscroll"> BB3_24</a>, <a href="#C-PPP_01" class="bgscroll"> C-PPP_03</a>, <a href="#C-PPP_04" class="bgscroll"> C-PPP_04</a></br> | ||
− | GG-products are then transformed into competent cells. Colonies with specific antibiotic resistances were selected | + | GG-products are then transformed into competent cells. Colonies with specific antibiotic resistances were selected by using antibiotic-containing media. The next day, positives clones were confirmed via an OneTaq colony PCR and a gel electrophoresis before a Miniprep was made.</br> |
<br>• A temperature-sensitivity test was performed for cells with pSIM5, a temperature sensitive plasmid. An overnight culture was incubated at 37°C and a control was incubated at 28°C. The overnight culture at 37°C was tested as positive and lost the plasmid, while the control maintained its plasmid.</br> | <br>• A temperature-sensitivity test was performed for cells with pSIM5, a temperature sensitive plasmid. An overnight culture was incubated at 37°C and a control was incubated at 28°C. The overnight culture at 37°C was tested as positive and lost the plasmid, while the control maintained its plasmid.</br> | ||
<br>• Two clones of yeast cells carrying the Cas9 plasmid made competent for the next transformation</br> | <br>• Two clones of yeast cells carrying the Cas9 plasmid made competent for the next transformation</br> | ||
Line 676: | Line 676: | ||
<p> | <p> | ||
<br>• Golden Gate Assembly of <a href="#BB1_26" class="bgscroll"> BB1_26</a>, <a href="#BB2_23" class="bgscroll"> BB2_23</a>, BB3_02 (unsuccessful), <a href="#BB3_12" class="bgscroll"> BB3_12</a>, <a href="#BB3_16" class="bgscroll"> BB3_16</a>, <a href="#BB3_17" class="bgscroll"> BB3_17</a>, <a href="#BB3_20" class="bgscroll"> BB3_20</a>, <a href="#BB3_22" class="bgscroll"> BB3_22</a>, BB3_28 (unsuccessful), <a href="#C-PPP_04" class="bgscroll"> C-PPP_05</a>, <a href="#C-PPP_04" class="bgscroll"> C-PPP_06</a></br> | <br>• Golden Gate Assembly of <a href="#BB1_26" class="bgscroll"> BB1_26</a>, <a href="#BB2_23" class="bgscroll"> BB2_23</a>, BB3_02 (unsuccessful), <a href="#BB3_12" class="bgscroll"> BB3_12</a>, <a href="#BB3_16" class="bgscroll"> BB3_16</a>, <a href="#BB3_17" class="bgscroll"> BB3_17</a>, <a href="#BB3_20" class="bgscroll"> BB3_20</a>, <a href="#BB3_22" class="bgscroll"> BB3_22</a>, BB3_28 (unsuccessful), <a href="#C-PPP_04" class="bgscroll"> C-PPP_05</a>, <a href="#C-PPP_04" class="bgscroll"> C-PPP_06</a></br> | ||
− | GG-products are then transformed into competent cells. Colonies with specific antibiotic resistances were selected | + | GG-products are then transformed into competent cells. Colonies with specific antibiotic resistances were selected by using antibiotic-containing media. The next day, positives clones were confirmed via an OneTaq colony PCR and a gel electrophoresis before a Miniprep was made.</br> |
<br>• Overnight cultures of <a href="#C-PPP_04" class="bgscroll"> C-PPP_04</a> tested for temperature sensitivity</br> | <br>• Overnight cultures of <a href="#C-PPP_04" class="bgscroll"> C-PPP_04</a> tested for temperature sensitivity</br> | ||
<br>• Sent for Sequencing: <a href="#C-PPP_04" class="bgscroll"> C-PPP_05</a>, <a href="#C-PPP_04" class="bgscroll"> C-PPP_06</a>, <a href="#BB3_20" class="bgscroll"> BB3_20</a>, <a href="#BB3_22" class="bgscroll"> BB3_22</a></br> | <br>• Sent for Sequencing: <a href="#C-PPP_04" class="bgscroll"> C-PPP_05</a>, <a href="#C-PPP_04" class="bgscroll"> C-PPP_06</a>, <a href="#BB3_20" class="bgscroll"> BB3_20</a>, <a href="#BB3_22" class="bgscroll"> BB3_22</a></br> | ||
Line 724: | Line 724: | ||
Each PCR was loaded on a preparative gel and cut out before undergoing PCR-purification according to protocol. | Each PCR was loaded on a preparative gel and cut out before undergoing PCR-purification according to protocol. | ||
<br><br>• Golden Gate Assembly of <a href="#BB1_27" class="bgscroll"> BB1_27</a>, BB3_01 (unsuccessful), <a href="#BB3_03" class="bgscroll"> BB3_03</a>, <a href="#BB3_30" class="bgscroll"> BB3_30</a>, <a href="#BB3_31" class="bgscroll"> BB3_31</a>, <a href="#BB3_32" class="bgscroll"> BB3_32</a>, <a href="#BB3_33" class="bgscroll"> BB3_33</a></br> | <br><br>• Golden Gate Assembly of <a href="#BB1_27" class="bgscroll"> BB1_27</a>, BB3_01 (unsuccessful), <a href="#BB3_03" class="bgscroll"> BB3_03</a>, <a href="#BB3_30" class="bgscroll"> BB3_30</a>, <a href="#BB3_31" class="bgscroll"> BB3_31</a>, <a href="#BB3_32" class="bgscroll"> BB3_32</a>, <a href="#BB3_33" class="bgscroll"> BB3_33</a></br> | ||
− | GG-products are then transformed into competent cells. Colonies with specific antibiotic resistances were selected | + | GG-products are then transformed into competent cells. Colonies with specific antibiotic resistances were selected by using antibiotic-containing media. The next day, positives clones were confirmed via an OneTaq colony PCR and a gel electrophoresis before a Miniprep was made.</br> |
<br>• Transformation of <a href="#BB3_32" class="bgscroll"> BB3_32</a> and <a href="#BB3_31" class="bgscroll"> BB3_31</a> into yeast cells</br> | <br>• Transformation of <a href="#BB3_32" class="bgscroll"> BB3_32</a> and <a href="#BB3_31" class="bgscroll"> BB3_31</a> into yeast cells</br> | ||
<br>• <a href="#BB3_31" class="bgscroll"> BB3_31</a> and <a href="#BB3_32" class="bgscroll"> BB3_32</a> cultivated in YP+G418, a yeast peptone media</br> for testing of the GFP expression in a plate reader. | <br>• <a href="#BB3_31" class="bgscroll"> BB3_31</a> and <a href="#BB3_32" class="bgscroll"> BB3_32</a> cultivated in YP+G418, a yeast peptone media</br> for testing of the GFP expression in a plate reader. | ||
Line 763: | Line 763: | ||
<br>•Golden Gate Assembly of BB3_01 (unsuccessful), <a href="#C-PPP_07" class="bgscroll">C-PPP_07</a>, <a href="#C-PPP_07" class="bgscroll"> C-PPP_08</a>, <a href="#C-PPP_07" class="bgscroll"> C-PPP_09</a>, <a href="#C-PPP_10" class="bgscroll">C-PPP_10</a>, <a href="#BB3_33" class="bgscroll">BB3_33</a></br> | <br>•Golden Gate Assembly of BB3_01 (unsuccessful), <a href="#C-PPP_07" class="bgscroll">C-PPP_07</a>, <a href="#C-PPP_07" class="bgscroll"> C-PPP_08</a>, <a href="#C-PPP_07" class="bgscroll"> C-PPP_09</a>, <a href="#C-PPP_10" class="bgscroll">C-PPP_10</a>, <a href="#BB3_33" class="bgscroll">BB3_33</a></br> | ||
− | GG-products are then transformed into competent cells. Colonies with specific antibiotic resistances were selected | + | GG-products are then transformed into competent cells. Colonies with specific antibiotic resistances were selected by using antibiotic-containing media. The next day, positive clones were confirmed via an OneTaq colony PCR and a gel electrophoresis before a Miniprep was made.</br> |
<br>•Minipreparation for plasmid DNA extraction: <a href="#BB3_12" class="bgscroll">BB3_12</a>, <a href="#BB3_30" class="bgscroll">BB3_30</a>, <a href="#BB3_15" class="bgscroll">BB3_15</a></br> | <br>•Minipreparation for plasmid DNA extraction: <a href="#BB3_12" class="bgscroll">BB3_12</a>, <a href="#BB3_30" class="bgscroll">BB3_30</a>, <a href="#BB3_15" class="bgscroll">BB3_15</a></br> | ||
Line 829: | Line 829: | ||
Each PCR was loaded on a preparative gel and cut out before undergoing PCR-purification | Each PCR was loaded on a preparative gel and cut out before undergoing PCR-purification | ||
<br><br>• Golden Gate Assembly of <a href="#BB3_12" class="bgscroll"> BB3_12</a>, <a href="#BB3_34" class="bgscroll"> BB3_34</a>, <a href="#BB3_35 Speziale" class="bgscroll"> BB3_35 Speziale</a>, <a href="#BB3_35" class="bgscroll"> BB3_35</a>, <a href="#BB3_36" class="bgscroll"> BB3_36</a>, <a href="#BB3_37" class="bgscroll"> BB3_37</a>, <a href="#BB3_38" class="bgscroll"> BB3_38</a>, <a href="#C-PPP_10" class="bgscroll"> C-PPP_12</a></br> | <br><br>• Golden Gate Assembly of <a href="#BB3_12" class="bgscroll"> BB3_12</a>, <a href="#BB3_34" class="bgscroll"> BB3_34</a>, <a href="#BB3_35 Speziale" class="bgscroll"> BB3_35 Speziale</a>, <a href="#BB3_35" class="bgscroll"> BB3_35</a>, <a href="#BB3_36" class="bgscroll"> BB3_36</a>, <a href="#BB3_37" class="bgscroll"> BB3_37</a>, <a href="#BB3_38" class="bgscroll"> BB3_38</a>, <a href="#C-PPP_10" class="bgscroll"> C-PPP_12</a></br> | ||
− | GG-products are then transformed into competent cells. Colonies with specific antibiotic resistances were selected | + | GG-products are then transformed into competent cells. Colonies with specific antibiotic resistances were selected by using antibiotic-containing media. The next day, positives clones were confirmed via an OneTaq colony PCR and a gel electrophoresis before a Miniprep was made.</br> |
<br>• Lethality-Test of <a href="#C-PPP_10" class="bgscroll"> C-PPP_11</a> and <a href="#C-PPP_10" class="bgscroll"> C-PPP_12</a></br> | <br>• Lethality-Test of <a href="#C-PPP_10" class="bgscroll"> C-PPP_11</a> and <a href="#C-PPP_10" class="bgscroll"> C-PPP_12</a></br> | ||
<div id="BB3_34" class="modalDialog "> | <div id="BB3_34" class="modalDialog "> | ||
Line 866: | Line 866: | ||
<p> | <p> | ||
<br>• Golden Gate Assembly of <a href="#BB3_27" class="bgscroll"> BB3_27</a>, <a href="#BB3_36" class="bgscroll"> BB3_36</a>, <a href="#BB3_37" class="bgscroll"> BB3_37</a>, <a href="#BB3_38" class="bgscroll"> BB3_38</a>, <a href="#BB3_39" class="bgscroll"> BB3_39</a>, <a href="#BB3_40" class="bgscroll"> BB3_40</a>, <a href="#BB3_43" class="bgscroll"> BB3_43</a>, <a href="#C-PPP_10" class="bgscroll"> C-PPP_10</a>, <a href="#C-PPP_10" class="bgscroll"> C-PPP_11</a>, <a href="#C-PPP_10" class="bgscroll"> C-PPP_12</a>, C-PPP_12 (+ #97)</br> | <br>• Golden Gate Assembly of <a href="#BB3_27" class="bgscroll"> BB3_27</a>, <a href="#BB3_36" class="bgscroll"> BB3_36</a>, <a href="#BB3_37" class="bgscroll"> BB3_37</a>, <a href="#BB3_38" class="bgscroll"> BB3_38</a>, <a href="#BB3_39" class="bgscroll"> BB3_39</a>, <a href="#BB3_40" class="bgscroll"> BB3_40</a>, <a href="#BB3_43" class="bgscroll"> BB3_43</a>, <a href="#C-PPP_10" class="bgscroll"> C-PPP_10</a>, <a href="#C-PPP_10" class="bgscroll"> C-PPP_11</a>, <a href="#C-PPP_10" class="bgscroll"> C-PPP_12</a>, C-PPP_12 (+ #97)</br> | ||
− | GG-products are then transformed into competent cells. Colonies with specific antibiotic resistances were selected | + | GG-products are then transformed into competent cells. Colonies with specific antibiotic resistances were selected by using antibiotic-containing media. The next day, positives clones were confirmed via an OneTaq colony PCR and a gel electrophoresis before a Miniprep was made.</br> |
<br>• Transformation and OneTaq colony PCR of yeast</br> | <br>• Transformation and OneTaq colony PCR of yeast</br> | ||
<div id="BB3_27" class="modalDialog "> | <div id="BB3_27" class="modalDialog "> | ||
Line 908: | Line 908: | ||
Each PCR was loaded on a preparative gel and cut out before undergoing PCR-purification | Each PCR was loaded on a preparative gel and cut out before undergoing PCR-purification | ||
<br><br>• Golden Gate Assembly of <a href="#BB2_56" class="bgscroll">BB2_56</a>, <a href="#BB3_09" class="bgscroll"> BB3_09</a>, <a href="#BB3_42" class="bgscroll"> BB3_42</a>, C-PPP_15 (unsuccessful), <a href="#C-PPP_25" class="bgscroll"> C-PPP_26</a>, C-PPP_27 (unsuccessful), <a href="#C-PPP_28" class="bgscroll"> C-PPP_28</a>, <a href="#C-PPP_31" class="bgscroll"> C-PPP_31</a>, <a href="#C-PPP_34" class="bgscroll"> C-PPP_34</a></br> | <br><br>• Golden Gate Assembly of <a href="#BB2_56" class="bgscroll">BB2_56</a>, <a href="#BB3_09" class="bgscroll"> BB3_09</a>, <a href="#BB3_42" class="bgscroll"> BB3_42</a>, C-PPP_15 (unsuccessful), <a href="#C-PPP_25" class="bgscroll"> C-PPP_26</a>, C-PPP_27 (unsuccessful), <a href="#C-PPP_28" class="bgscroll"> C-PPP_28</a>, <a href="#C-PPP_31" class="bgscroll"> C-PPP_31</a>, <a href="#C-PPP_34" class="bgscroll"> C-PPP_34</a></br> | ||
− | GG-products are then transformed into competent cells. Colonies with specific antibiotic resistances were selected | + | GG-products are then transformed into competent cells. Colonies with specific antibiotic resistances were selected by using antibiotic-containing media. The next day, positives clones were confirmed via an OneTaq colony PCR and a gel electrophoresis before a Miniprep was made.</br> |
<br>• Yeast S288C made electro-competent</br> | <br>• Yeast S288C made electro-competent</br> | ||
<br>• Toulouse Collaboration: for further information, please visit our <a href="https://2017.igem.org/Team:BOKU-Vienna/Collaborations" target=_"blank">Collaboration</a> site.</br> | <br>• Toulouse Collaboration: for further information, please visit our <a href="https://2017.igem.org/Team:BOKU-Vienna/Collaborations" target=_"blank">Collaboration</a> site.</br> | ||
Line 948: | Line 948: | ||
Each PCR was loaded on a preparative gel and cut out before undergoing PCR-purification. | Each PCR was loaded on a preparative gel and cut out before undergoing PCR-purification. | ||
<br><br>• Golden Gate Assembly of <a href="#BB1_32" class="bgscroll"> BB1_32</a>, <a href="#BB2_51" class="bgscroll"> BB2_51</a>, <a href="#BB2_52" class="bgscroll"> BB2_52</a>, <a href="#BB2_53" class="bgscroll"> BB2_53</a>, <a href="#BB2_54" class="bgscroll"> BB2_54</a>, <a href="#BB2_55" class="bgscroll"> BB2_55</a>, <a href="#BB2_57" class="bgscroll"> BB2_57</a>, BB3_41 (unsuccessful), <a href="#BB3_43" class="bgscroll"> BB3_43</a>, <a href="#BB3_45" class="bgscroll"> BB3_45</a>, <a href="#BB3_46" class="bgscroll"> BB3_46</a>, <a href="#BB3_47" class="bgscroll"> BB3_47</a>, <a href="#BB3_48" class="bgscroll"> BB3_48</a>, <a href="#BB3_49" class="bgscroll"> BB3_49</a>, <a href="#C-PPP_13" class="bgscroll"> C-PPP_14</a>, <a href="#C-PPP_13" class="bgscroll"> C-PPP_15</a>, <a href="#C-PPP_16" class="bgscroll"> C-PPP_16</a>, <a href="#C-PPP_19" class="bgscroll"> C-PPP_19</a>, <a href="#C-PPP_19" class="bgscroll"> C-PPP_20</a>, <a href="#C-PPP_19" class="bgscroll"> C-PPP_21</a>, <a href="#C-PPP_22" class="bgscroll"> C-PPP_22</a>, <a href="#C-PPP_28" class="bgscroll"> C-PPP_28</a>, <a href="#C-PPP_31" class="bgscroll"> C-PPP_31</a>, <a href="#C-PPP_31" class="bgscroll"> C-PPP_33</a>, <a href="#C-PPP_31" class="bgscroll"> C-PPP_33</a>, <a href="#C-PPP_34" class="bgscroll"> C-PPP_34</a></br> | <br><br>• Golden Gate Assembly of <a href="#BB1_32" class="bgscroll"> BB1_32</a>, <a href="#BB2_51" class="bgscroll"> BB2_51</a>, <a href="#BB2_52" class="bgscroll"> BB2_52</a>, <a href="#BB2_53" class="bgscroll"> BB2_53</a>, <a href="#BB2_54" class="bgscroll"> BB2_54</a>, <a href="#BB2_55" class="bgscroll"> BB2_55</a>, <a href="#BB2_57" class="bgscroll"> BB2_57</a>, BB3_41 (unsuccessful), <a href="#BB3_43" class="bgscroll"> BB3_43</a>, <a href="#BB3_45" class="bgscroll"> BB3_45</a>, <a href="#BB3_46" class="bgscroll"> BB3_46</a>, <a href="#BB3_47" class="bgscroll"> BB3_47</a>, <a href="#BB3_48" class="bgscroll"> BB3_48</a>, <a href="#BB3_49" class="bgscroll"> BB3_49</a>, <a href="#C-PPP_13" class="bgscroll"> C-PPP_14</a>, <a href="#C-PPP_13" class="bgscroll"> C-PPP_15</a>, <a href="#C-PPP_16" class="bgscroll"> C-PPP_16</a>, <a href="#C-PPP_19" class="bgscroll"> C-PPP_19</a>, <a href="#C-PPP_19" class="bgscroll"> C-PPP_20</a>, <a href="#C-PPP_19" class="bgscroll"> C-PPP_21</a>, <a href="#C-PPP_22" class="bgscroll"> C-PPP_22</a>, <a href="#C-PPP_28" class="bgscroll"> C-PPP_28</a>, <a href="#C-PPP_31" class="bgscroll"> C-PPP_31</a>, <a href="#C-PPP_31" class="bgscroll"> C-PPP_33</a>, <a href="#C-PPP_31" class="bgscroll"> C-PPP_33</a>, <a href="#C-PPP_34" class="bgscroll"> C-PPP_34</a></br> | ||
− | GG-products are then transformed into competent cells. Colonies with specific antibiotic resistances were selected | + | GG-products are then transformed into competent cells. Colonies with specific antibiotic resistances were selected by using antibiotic-containing media. The next day, positives clones were confirmed via an OneTaq colony PCR and a gel electrophoresis before a Miniprep was made.</br> |
<br>• Heidelberg Collaboration: for further information, please visit our <a href="https://2017.igem.org/Team:BOKU-Vienna/Collaborations" target=_"blank">Collaboration</a> site.</br> | <br>• Heidelberg Collaboration: for further information, please visit our <a href="https://2017.igem.org/Team:BOKU-Vienna/Collaborations" target=_"blank">Collaboration</a> site.</br> | ||
Line 1,033: | Line 1,033: | ||
<p> | <p> | ||
<br>• Golden Gate Assembly of <a href="#C-PPP_37" class="bgscroll"> C-PPP_37</a>, <a href="#C-PPP_37" class="bgscroll"> C-PPP_38</a>, <a href="#C-PPP_37" class="bgscroll"> C-PPP_39</a></br> | <br>• Golden Gate Assembly of <a href="#C-PPP_37" class="bgscroll"> C-PPP_37</a>, <a href="#C-PPP_37" class="bgscroll"> C-PPP_38</a>, <a href="#C-PPP_37" class="bgscroll"> C-PPP_39</a></br> | ||
− | GG-products are then transformed into competent cells. Colonies with specific antibiotic resistances were selected | + | GG-products are then transformed into competent cells. Colonies with specific antibiotic resistances were selected by using antibiotic-containing media. The next day, positives clones were confirmed via an OneTaq colony PCR and a gel electrophoresis before a Miniprep was made. |
<div id="C-PPP_37" class="modalDialog "> | <div id="C-PPP_37" class="modalDialog "> | ||
<div><a href="#close" title="Close" class="close">X</a> | <div><a href="#close" title="Close" class="close">X</a> |
Revision as of 15:28, 1 November 2017
Notebook.
All protocols we used for the methods can be found here:
Protocol
For further information regarding our Golden Gate Assembly products, please refer to our part collection site. The list of our primers can be found here.
Week 1 (03/07-07/07)
Week 2 (10/07-14/07)
Week 3 (17/07-21/07)
Week 4 (24/07-28/07)
Week 5 (31/07-04/08)
Week 6 (07/08-11/08)
Week 7 (14/08-18/08)
Week 8 (21/08-25/08)
Week 9 (28/08-01/09)
Week 10 (04/09-08/09)
Week 11 (11/09-15/09)
Week 12 (18/09-22/09)
Week 13 (25/09-29/09)
Week 14 (02/10-06/10)
Week 15 (09/10-13/10)